Cargando…

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306549/ https://www.ncbi.nlm.nih.gov/pubmed/25621883 http://dx.doi.org/10.1371/journal.pone.0116994

Ejemplares similares

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014)

Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Correction: Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression
por: Lu, Weiqun, et al.
Publicado: (2018)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
por: Chaudhary, Sapana, et al.
Publicado: (2022)

Serum Galectin-3 as a Potential Marker for Gastric Cancer
por: Cheng, Daye, et al.
Publicado: (2015)

Correction to: Circulating galectin-3 levels and diabetic nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023)

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
por: Li, Anqi, et al.
Publicado: (2017)

Correction to: Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
por: Zhang, Chuan-xia, et al.
Publicado: (2022)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Correction to: Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
Publicado: (2023)

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia
por: Yoeli, Dor, et al.
Publicado: (2022)

Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
por: Capone, Emily, et al.
Publicado: (2021)

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021)

Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
por: Nangia-Makker, Pratima, et al.
Publicado: (2022)

Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection
por: Schummer, Michèl, et al.
Publicado: (2010)

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2023)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015)

Correction: Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer
por: Schummer, Michèl, et al.
Publicado: (2016)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021)

Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Zhang, Zengjie, et al.
Publicado: (2021)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Correction: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers
Publicado: (2019)

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis
por: Kram, Michael
Publicado: (2023)

Correction: Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
por: Qin, Rui, et al.
Publicado: (2022)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
por: Femel, Julia, et al.
Publicado: (2022)

Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
por: Ouyang, Zhengxiao, et al.
Publicado: (2023)

Correction: Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
por: Gao, Mei, et al.
Publicado: (2020)

Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
por: Park, Ah-Mee, et al.
Publicado: (2020)

Correction: Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice
por: Zhao, Yiming, et al.
Publicado: (2023)

Correction: Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
por: Gedaj, Aleksandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m5bkng62ec9naclg7qdtjkivjh